26 related articles for article (PubMed ID: 9058162)
1. Evaluation of Lapatinib Powder-Entrapped Biodegradable Polymeric Microstructures Fabricated by X-Ray Lithography for a Targeted and Sustained Drug Delivery System.
Jeong EG; Yoo HJ; Song B; Kim HP; Han SW; Kim TY; Cho DD
Materials (Basel); 2015 Feb; 8(2):519-534. PubMed ID: 28787954
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Analysis of p53, Ki-67, CD44, HER-2/neu Expression Patterns in Gastric Cancer, and Their Association with One Year Survival in North-West of Iran.
Sanaat Z; Halimi M; Ghojezadeh M; Pirovi AH; Gharamaleki JV; Ziae AE; Kermani IA
Int J Hematol Oncol Stem Cell Res; 2013; 7(3):15-20. PubMed ID: 24505530
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of HER2/neu expression in gastric cancer.
Ananiev J; Gulubova M; Manolova I; Tchernev G
Wien Klin Wochenschr; 2011 Jul; 123(13-14):450-4. PubMed ID: 21739203
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics in chemotherapy for GI tract cancer.
Furuta T
J Gastroenterol; 2009; 44(10):1016-25. PubMed ID: 19728007
[TBL] [Abstract][Full Text] [Related]
5. HER-2/neu amplification is an independent prognostic factor in gastric cancer.
Park DI; Yun JW; Park JH; Oh SJ; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Yoo CH; Son BH; Cho EY; Chae SW; Kim EJ; Sohn JH; Ryu SH; Sepulveda AR
Dig Dis Sci; 2006 Aug; 51(8):1371-9. PubMed ID: 16868827
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome analysis of human gastric cancer.
Oh JH; Yang JO; Hahn Y; Kim MR; Byun SS; Jeon YJ; Kim JM; Song KS; Noh SM; Kim S; Yoo HS; Kim YS; Kim NS
Mamm Genome; 2005 Dec; 16(12):942-54. PubMed ID: 16341674
[TBL] [Abstract][Full Text] [Related]
7. The expression of c-erbB-1 and c-erbB-2 in Iranian patients with gastric carcinoma.
Ghaderi A; Vasei M; Maleck-Hosseini SA; Gharesi-Fard B; Khodami M; Doroudchi M; Modjtahedi H
Pathol Oncol Res; 2002; 8(4):252-6. PubMed ID: 12579211
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-erbB-2 oncoprotein in gastric carcinoma: correlation with histopathologic characteristics and analysis of Ki-67.
Dursun A; Poyraz A; Celik B; Akyol G
Pathol Oncol Res; 1999; 5(2):104-6. PubMed ID: 10393360
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer.
Tokunaga A; Onda M; Okuda T; Teramoto T; Fujita I; Mizutani T; Kiyama T; Yoshiyuki T; Nishi K; Matsukura N
Cancer; 1995 Mar; 75(6 Suppl):1418-25. PubMed ID: 7889468
[TBL] [Abstract][Full Text] [Related]
10. [Stomach cancer. Morphology].
Nasierowska-Guttmejer A; Majewski P; Malinowska M
Pol J Pathol; 2013 Dec; 64(4 Suppl 2):s27-39. PubMed ID: 24893506
[No Abstract] [Full Text] [Related]
11. c-erbB-2 expression is predictive for lymphatic spread of clinical gastric carcinoma.
Orita H; Maehara Y; Emi Y; Kakeji Y; Baba H; Korenaga D; Sugimachi K
Hepatogastroenterology; 1997; 44(13):294-8. PubMed ID: 9058162
[TBL] [Abstract][Full Text] [Related]
12. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of c-erbB-2 and DNA ploidy patterns in gastric carcinoma recurrence.
Noguchi Y; Tsuburaya A; Makino T; Fukuzawa K; Nomura K; Yoshikawa T; Imada T; Amano T; Matsumoto A
Int Surg; 1993; 78(2):107-11. PubMed ID: 8102619
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer.
Yonemura Y; Ninomiya I; Yamaguchi A; Fushida S; Kimura H; Ohoyama S; Miyazaki I; Endou Y; Tanaka M; Sasaki T
Cancer Res; 1991 Feb; 51(3):1034-8. PubMed ID: 1670998
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of c-erbB2 oncoprotein expression in stomach carcinoma].
Gong Z; Luo E; Lu Q
Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):299-301. PubMed ID: 9387327
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
